United Capital Financial Advisors’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-2,798
| Closed | -$514K | – | 1254 |
|
|
2021
Q2 | $514K | Buy |
2,798
+28
| +1% | +$5.14K | ﹤0.01% | 851 |
|
|
2021
Q1 | $424K | Sell |
2,770
-144
| -5% | -$22K | ﹤0.01% | 890 |
|
|
2020
Q4 | $455K | Buy |
2,914
+312
| +12% | +$48.7K | ﹤0.01% | 866 |
|
|
2020
Q3 | $298K | Buy |
2,602
+453
| +21% | +$51.9K | ﹤0.01% | 951 |
|
|
2020
Q2 | $241K | Buy |
+2,149
| New | +$241K | ﹤0.01% | 1042 |
|
|
2017
Q2 | – | Sell |
-1,877
| Closed | -$228K | – | 1325 |
|
|
2017
Q1 | $228K | Sell |
1,877
-407
| -18% | -$49.4K | ﹤0.01% | 1148 |
|
|
2016
Q4 | $279K | Sell |
2,284
-106
| -4% | -$12.9K | ﹤0.01% | 1080 |
|
|
2016
Q3 | $293K | Sell |
2,390
-223
| -9% | -$27.3K | ﹤0.01% | 1081 |
|
|
2016
Q2 | $306K | Buy |
2,613
+687
| +36% | +$80.5K | ﹤0.01% | 1031 |
|
|
2016
Q1 | $268K | Buy |
1,926
+237
| +14% | +$33K | ﹤0.01% | 1031 |
|
|
2015
Q4 | $322K | Buy |
1,689
+205
| +14% | +$39.1K | ﹤0.01% | 999 |
|
|
2015
Q3 | $232K | Buy |
1,484
+249
| +20% | +$38.9K | ﹤0.01% | 1123 |
|
|
2015
Q2 | $223K | Buy |
+1,235
| New | +$223K | ﹤0.01% | 1153 |
|